Bicara Therapeutics Inc (BCAX)
$9.13 -6.17% Close Oct 30, 2026 Live
Bicara Therapeutics stock today
Bicara Therapeutics closed at $9.13 on October 30, 2026, down 6.17% on the day. Over the past year it returned -44.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $600 million.
$10.00$20.00$30.00
NovJan 2026MarMayJulSep
| Period | BCAX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -50.9% | -0.9% |
| 3 months | -65.2% | +2.1% |
| Year to date | -45.8% | +11.7% |
| 1 year | -44.5% | +12.4% |
Key statistics
- Market value
- $600M
- 52-week range
- $9.13 to $30.40
- Next report
- Nov 10, 2026
About Bicara Therapeutics
Biopharmaceutical company developing cell therapy treatments.
Sector: Health Care
More on Bicara Therapeutics
- Returns: what $1,000 became$1,000 one year ago is $554.68 today
No forecast, no recommendation. This page describes Bicara Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.